Form 4: Medpace Executive Exercises Stock Options

Sentiment:

Insider Transaction Report


Medpace Holdings' Executive VP of Operations, Susan E. Burwig, exercised 12,000 stock options and acquired common stock.

Summary

  • Susan E. Burwig, Executive VP of Operations at Medpace Holdings, Inc. (MEDP), reported a transaction on March 18, 2026.
  • Burwig exercised 12,000 employee stock options at a price of $166.73 per share.
  • Following the exercise, 12,000 shares of common stock were acquired.
  • The options had vested in full on October 27, 2025, and have an expiration date of October 27, 2026.
  • After this transaction, Burwig directly beneficially owns 70,484 shares of common stock.
  • Additionally, Burwig directly beneficially owns 11,028 derivative securities (employee stock options).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal, as a high-ranking executive exercising options and increasing their direct ownership stake typically indicates strong confidence in the company's current valuation and future growth trajectory.

Positives

  • The exercise of stock options by a high-level executive, Susan E. Burwig, indicates confidence in the company's future performance and valuation at the exercise price.
  • An increase in direct beneficial ownership by an executive aligns management's interests more closely with those of shareholders.

Future Outlook

This filing does not contain specific forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider transactions, such as the exercise of stock options by a key executive, are often closely watched by investors as they can signal management's perception of the company's intrinsic value and future prospects. In the contract research organization (CRO) industry, executive confidence can be particularly impactful given the long-term nature of drug development cycles and the importance of strategic leadership.

Stakeholder Impact

  • Shareholders: The transaction may be viewed positively by shareholders as it demonstrates an executive's commitment and belief in the company's value, potentially boosting investor confidence.
  • Employees: May signal stability and confidence in the company's leadership and strategic direction.

Key Dates

DateDescription
10/27/2025Date when the employee stock option vested in full.
03/18/2026Transaction date for the exercise of employee stock options and acquisition of common stock.
03/19/2026Date the Form 4 was signed by the attorney-in-fact for Susan E. Burwig.
10/27/2026Expiration date of the employee stock option.

Recommendation

buy

The exercise of a significant number of stock options by a key executive, Susan E. Burwig, at a specific price and the subsequent increase in her direct beneficial ownership, signals strong insider confidence in Medpace Holdings' future performance and valuation. This action suggests that management believes the stock is a good investment at or above the exercise price, making it a positive indicator for potential investors.

Keywords

Medpace Holdings, MEDP, Insider Transaction, Form 4, Stock Options, Executive Compensation, Beneficial Ownership, Susan E. Burwig

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.